TCL Archive Grantees Not In Danger Of Losing Cost-Free Biological Materials, But Can’t Have Chemicals September 9, 1977
TCL Archive Senate Committee Adds $200 Mil. To NCI Request For FY92; Centers, Women’s Health, Targeted July 19, 1991
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
